Skip to content

Required propofol dose and time to emerge for anesthesia, affect by antiepileptics and disability

Required propofol dose and time to emerge for anesthesia, affect by antiepileptics and disability - The propofol required dose and the emergence in intravenous sedation for patient with disability

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000012882
Enrollment
300
Registered
2014-01-18
Start date
2007-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with neurological disorder who were treated under intravenous general anesthesia

Interventions

None listed

Sponsors

Kagoshima university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patient that an agreement was provided

Exclusion criteria

Exclusion criteria: The cases that did not use TCI and BIS or did not consent of study were excluded.

Design outcomes

Primary

MeasureTime frame
We measure predictive blood concentration, time for emergence and propofol dose.

Countries

Japan

Contacts

Public ContactKentaro OUCHI

Kagoshima University Anesthesia center

ken2006anes@yahoo.co.jp099-275-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026